Loading…

Recapturing disease response: A phase 2 study of carfilzomib 56 mg/m2 in patients with relapsed or refractory multiple myeloma who have progressed on carfilzomib 27 mg/m2

Saved in:

Bibliographic Details
Published in:	American journal of hematology 2020-02, Vol.95 (2), p.E51-E54
Main Authors:	Barley, Kevin, Sanchez, Larysa, Cho, Hearn J., Parekh, Samir, Madduri, Deepu, Richter, Joshua, Isola, Luis, Goldstein, Talia, Dhadwal, Amishi, Zarychta, Katarzyna, Sanchez, Gillian Morgan, Catamero, Donna, Verina, Daniel, Florendo, Erika, Yum, Moon‐hee, La, Lisa, Gullie, Jude, Chan, Elaine, Jagannath, Sundar, Chari, Ajai
Format:	Article
Language:	English
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!